JAY BHARAT MEHTA

DIN: 00043079

For latest information about the director, visit MCA.

JAY BHARAT MEHTA is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 00043079. JAY BHARAT MEHTA is/has been associated with 24 companies.

This is just one Director. Want to discover lot more?

Companies Associated With

Company Designation Date of Appointment
J. B. MODY ENTERPRISES LLP Designated Partner 25-Jun-2013
ANSUYA MODY ENTERPRISES LLP Designated Partner 25-Jun-2013
IFIUNIK ENTERPRISES LLP Designated Partner 28-Oct-2020
JYOTINDRA MODY VENTURES LLP Designated Partner 15-Jul-2015
SILVERSEAS ENTERPRISES LLP Designated Partner 17-Sep-2021
LEADDER TEAM LLP Designated Partner 17-Feb-2022
PERRIN ADVISORS LLP Partner 18-Sep-2023
UNIQUE PHARMACEUTICAL LABORATORIES LIMITED Director 30-Nov-2021
ANSUYA MODY ENTERPRISES PRIVATE LIMITED Director 31-May-2013
J. B. MODY ENTERPRISES PRIVATE LIMITED Director 31-May-2013
JYOTINDRA MODY HOLDINGS PRIVATE LIMITED Director 30-Sep-2010
ANSUYA MODY SECURITIES PRIVATE LIMITED Director 30-Sep-2010
LUXE WELLNESS PRIVATE LIMITED Director 30-Nov-2021

Past Companies Associated With

Company Designation Date of Appointment Date of Cessation
SYNIT DRUGS PVT LTD Additional Director 01-Aug-2008 30-Sep-2009
SYNIT DRUGS PVT LTD Director 30-Sep-2009 02-May-2016
UNIQUE PHARMACEUTICAL LABORATORIES LIMITED Additional Director 23-Dec-2020 30-Nov-2021
UNIQUE PHARMACEUTICAL LABORATORIES LIMITED Alternate Director 13-Mar-2006 24-Apr-2014
ANSUYA MODY ENTERPRISES PRIVATE LIMITED Additional Director 20-Nov-2012 31-May-2013
LIFETIME HEALTHCARE PRIVATE LIMITED Director 01-Apr-2005 21-Nov-2008
J. B. MODY ENTERPRISES PRIVATE LIMITED Additional Director 12-Nov-2012 31-May-2013
JYOTINDRA MODY HOLDINGS PRIVATE LIMITED Additional Director 28-Jan-2010 30-Sep-2010
ERAGON VENTURES LIMITED Alternate Director 13-Mar-2006 24-Apr-2014
ANSUYA MODY SECURITIES PRIVATE LIMITED Additional Director 28-Jan-2010 30-Sep-2010
LUXE WELLNESS PRIVATE LIMITED Additional Director 10-Jun-2021 30-Nov-2021

โ€œAssess financial performance of all companies under a director.โ€